However, the market has been warned against pre-Christmas trading assumptions.
Management are cautiously optimistic sales will continue to improve, although Middle East still struggling.
The results reflect a challenging period for the kiwifruit industry.
A premium is being placed on profitability, for tech companies.
The NZX-listed healthcare provider wants to the Government to ‘significantly’ increase funding.
The Government announced a $200m funding boost in November to close the pay gap between frontline health workers and nurses working in hospitals.
Company shifting incorporation to Australia but CEO affirms commitment to NZ operations.
Trading revenue for 2023 was up 27%.
Shares in Hallenstein Glasson surged ahead of its announced inclusion in the S&P/NZX50.
The company has signalled it needs to pay at least $25m to ASB Bank by October 6.